New stock news | Fuxin Futong Hong Kong stock IPO prospectus invalid
Fuxin Futong Technology Co., Ltd. (hereinafter referred to as "Fuxin Futong") submitted its Hong Kong IPO prospectus on December 19, 2025, which expired on December 19, 2026, six months after it was submitted. Zhong Yin International was its exclusive sponsor at the time of submission.
Futong Tech Co., Ltd. (hereinafter referred to as "Futong Tech"), whose Hong Kong IPO prospectus was submitted on December 19, 2025, expired after 6 months on December 19, 2026, with CICC being its exclusive sponsor at the time of submission.
The prospectus shows that Futong Tech has built a technical system of "one base, multiple capabilities, multiple applications", integrating hardware, software, and data analysis capabilities, relying on satellite communication, positioning, navigation, and timing technology. The company provides satellite time-space digital solutions for various application fields, supporting the integration and management of information in the air, space, land, and sea, enabling end users to real-time access, analyze, and apply data, thus achieving intelligent and precise operational management.
During the historical period, Futong Tech's business covered 25 provinces, autonomous regions, and municipalities in China. Its main clients include national communication operators and other local state-owned enterprises. According to Frost & Sullivan, based on 2024 revenue, Futong Tech is one of China's leading providers of satellite time-space digital solutions, ranking second in the digital transportation and digital ocean sectors.
Related Articles

On June 22, NEWBORNTOWN (09911) spent approximately 1.9969 million Hong Kong dollars to buy back 242,000 shares.

SHENZHEN INT'L (00152) issued 7.3302 million shares of interest-bearing shares.

Renhe Pharmacy (000650.SZ) subsidiary has obtained the registration certificate for Qingfei Tang granule medicine.
On June 22, NEWBORNTOWN (09911) spent approximately 1.9969 million Hong Kong dollars to buy back 242,000 shares.

SHENZHEN INT'L (00152) issued 7.3302 million shares of interest-bearing shares.

Renhe Pharmacy (000650.SZ) subsidiary has obtained the registration certificate for Qingfei Tang granule medicine.

RECOMMEND





